The small blue circles show the IC-volume (mean of left and right) from 72 males and the small red squares from 51 females as a function of age. حسب Pingling Kwok (14896191)

This is the data set that we used to reach the conclusions drawn in the manuscript with related metadata and methods. حسب Farayi Kaseke (19560197)

Antibiotic use in small animals by substance registration status. حسب Sarin Suwanpakdee (119683)

Descriptive statistics (means) for full sample and by lockdown status. حسب Drew B. Cameron (10687420)

Units of non-point source agricultural pollution. حسب Cangyu Li (10312677)

الموضوعات:

Scoring schemes for the assessment of skin and keel bone status in laying hens¹ [29]. حسب Lisa Jung (13264758)

Characteristics of the investigated laying hen flocks with numbers of assessed hens on-farm concerning skin and keel bone status. حسب Lisa Jung (13264758)

Mean scores and 95% CIs according to SARS-CoV-2 infection status and work-related determinants. حسب A. H. Ayesha Lavell (16734002)

Cumulative distribution of EQ-5D-3L utilities decreasingly ordered before and after the onset of cutaneous leishmaniasis symptoms. حسب Janaína de Pina Carvalho (12152812)

S1 File - Assessment and analysis of agricultural non-point source pollution loads in Henan, China: 2001–2023 حسب Cangyu Li (10312677)

الموضوعات:

Mental health status of respondents (n = 259). حسب Isha Aryal (22582068)

Participants by event status and sex. حسب Beat Knechtle (5504402)

Sampling point (Source: حسب Yonggang Huang (223155)

Content analysis of groups with decreased confidence. حسب Yasutaka Yanagita (11105508)

Association between mental health status and socio-demographic variables of respondents (n = 259). حسب Isha Aryal (22582068)

PAP I point mutations lead to a decrease in pYV PCN, plasmid stability, and T3SS activity. حسب Katherine Schubert (5452712)

The energy density of peak point with different freezing temperatures. حسب Liang Zhang (41392)

Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc حسب Lei Wang (6656)

"…The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …"

Estimates of average yearly citations of publications by scholars accused of scientific misconduct by retraction status and time. حسب Giulia Maimone (20833354)

Expected marginal mean QoL scores for two age cohorts over 2016–2024 in Gauteng, South Africa. حسب Edmore Marinda (286299)

الموضوعات: